x
Filter:
Filters applied
- Graphical Abstracts
- HRRemove HR filter
- 2022 - 2023Remove 2022 - 2023 filter
Author
- Anderson, Joseph C1
- Bang, Seungmin1
- Bazarova, Alina1
- Butterly, Lynn F1
- Cadei, Moris1
- Cannatelli, Rosanna1
- Cho, Jae Hee1
- Chung, Moon Jae1
- Danese, Silvio1
- Fujiwara, Yasuhiro1
- Fukunaga, Shusei1
- Furfaro, Federica1
- Ghosh, Subrata1
- Higashimori, Akira1
- Hisey, William1
- Hosomi, Shuhei1
- Iacucci, Marietta1
- Jo, Jung Hyun1
- Kamata, Noriko1
- Kang, Huapyong1
- Kim, Eui Joo1
- Kim, Yeon Suk1
- Labarile, Nunzia1
- Lee, Hee Seung1
- Lee, Kyong Joo1
Graphical Abstracts
4 Results
- New methods Clinical endoscopy
Covered versus uncovered double bare self-expandable metal stent for palliation of unresectable extrahepatic malignant biliary obstruction: a randomized controlled multicenter trial
Gastrointestinal EndoscopyVol. 97Issue 1p132–142.e2Published online: September 6, 2022- Se Woo Park
- Kyong Joo Lee
- Moon Jae Chung
- Jung Hyun Jo
- Hee Seung Lee
- Jeong Youp Park
- and others
Cited in Scopus: 2In a recent randomized controlled trial, a double bare metal stent (DBS) showed better stent patency than single-layer metal stents. However, clear evidence comparing the efficacy of uncovered (UCDBS) and partially covered (PCDBS) DBSs for distal malignant biliary obstruction (MBO) is lacking. Therefore, we compared the clinical outcomes including stent patency of UCDBSs versus PCDBSs. - Original article Clinical endoscopy
Long-term rebleeding rate and predictive factors of rebleeding after capsule endoscopy in patients with obscure GI bleeding
Gastrointestinal EndoscopyVol. 96Issue 6p956–969.e3Published online: July 15, 2022- Koji Otani
- Sunao Shimada
- Toshio Watanabe
- Yuji Nadatani
- Akira Higashimori
- Masaki Ominami
- and others
Cited in Scopus: 0The incidence of rebleeding in obscure GI bleeding (OGIB) remains unclear. This study used capsule endoscopy (CE) to determine the long-term rebleeding rate and predictive factors for rebleeding in patients with OGIB. - Original article Clinical endoscopy
Clinically significant serrated polyp detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry
Gastrointestinal EndoscopyVol. 96Issue 2p310–317Published online: March 8, 2022- Joseph C. Anderson
- William Hisey
- Todd A. Mackenzie
- Christina M. Robinson
- Amitabh Srivastava
- Reinier G.S. Meester
- and others
Cited in Scopus: 4Higher adenoma detection rates reduce the risk of postcolonoscopy colorectal cancer (PCCRC). Clinically significant serrated polyps (CSSPs; defined as any sessile serrated polyp, traditional serrated adenoma, large [≥1 cm] or proximal hyperplastic polyp >5 mm) also lead to PCCRC, but there are no data on associated CSSP detection rates (CSSDRs). We used data from the New Hampshire Colonoscopy Registry (NHCR) to investigate the association between PCCRC risk and endoscopist CSSDR. - Original article Clinical endoscopy
Reproducibility of the electronic chromoendoscopy PICaSSO score (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis using multiple endoscopic platforms: a prospective multicenter international study (with video)
Gastrointestinal EndoscopyVol. 96Issue 1p73–83Published online: February 16, 2022- Rosanna Cannatelli
- Alina Bazarova
- Federica Furfaro
- Tommaso Lorenzo Parigi
- Davide Zardo
- Olga Maria Nardone
- and others
Cited in Scopus: 3Endoscopic and histologic remission (HR) are key therapeutic targets in the management of ulcerative colitis (UC). The aim of this study was to evaluate the reproducibility of the Paddington International virtual ChromoendoScopy ScOre (PICaSSO), a virtual chromoendoscopy score originally validated by use of the iSCAN platform, with the narrow-band imaging (NBI), linked-color imaging (LCI), and blue-laser imaging (BLI) platforms.